Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 6.28
-0.02 (-0.32%)
Aug 14, 2025, 4:05 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 93.66 million as of August 14, 2025. Its market cap has decreased by -27.16% in one year.
Market Cap
93.66M
Enterprise Value
82.40M
Revenue
6.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.28
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 93.66M, a decrease of -15.27%. That is a compound annual growth rate of -3.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 93.66M | -10.57% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.72B |
| NEUCA | 2.94B |
| Voxel | 1.86B |
| Synektik Spólka Akcyjna | 1.81B |
| Celon Pharma | 1.24B |
| Ryvu Therapeutics | 709.79M |
| Selvita | 607.57M |
| Centrum Medyczne ENEL-MED | 537.33M |